SOMATOSTATINA - OCTREOTIDE IN MALATTIE LINFOPROLIFERATIVE

Am J Gastroenterol. 1999 Jan;94(1):278-9.Successful treatment of an advanced hepatocellular carcinoma with the long-actingsomatostatin analog lanreotide.Raderer M, Hejna MH, Kurtaran A, Kornek GV, Valencak JB, Oberhuber G, Vorbeck F, VirgoliniI, Scheithauer W.Treatment options for hepatocellular cancer apart from surgical resection are limited becauseof the drug-refractory nature of this disease. Little is known about the role ofsomatostatin-receptors in hepatocellular cancer, and somatostatin analogs have notbeen investigated for treatment of this malignancy. We present the case of a 68-yr-oldmale, who was successfully treated with the long-acting somatostatin analog lanreotide.